Theratechnologies Issues Earnings Results
| THTX Stock | USD 1.18 0.04 3.28% |
Slightly above 67% of Theratechnologies' investor base is looking to short. The analysis of overall sentiment of trading Theratechnologies stock suggests that many investors are alarmed at this time. Theratechnologies' investing sentiment can be driven by a variety of factors including economic data, Theratechnologies' earnings reports, geopolitical events, and overall market trends.
Theratechnologies |
Theratechnologies announced its quarterly earnings results on Thursday. The company reported 0.06 earnings per share for the quarter, beating the consensus estimate of 0.03 by 0.03, Yahoo Finance reports. During the same quarter last year, the firm earned earnings per share. Theratechnologies updated its FY 2024 guidance to
Read at thelincolnianonline.com
 |
Theratechnologies Fundamental Analysis
We analyze Theratechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Theratechnologies is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Theratechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theratechnologies stock to make a market-neutral strategy. Peer analysis of Theratechnologies could also be used in its relative valuation, which is a method of valuing Theratechnologies by comparing valuation metrics with similar companies.
Peers
Theratechnologies Related Equities
| VRCA | Verrica Pharmaceuticals | 11.71 | ||||
| PEPG | PepGen | 6.69 | ||||
| VIGL | Vigil Neuroscience | 4.55 | ||||
| BCAB | Bioatla | 4.46 | ||||
| VINC | Vincerx Pharma | 4.00 | ||||
| TARS | Tarsus Pharmaceuticals | 2.38 | ||||
| OPT | Opthea | 1.83 | ||||
| CNTA | Centessa Pharmaceuticals | 1.73 | ||||
| IVA | Inventiva | 1.52 | ||||
| GNFT | Genfit | 0.95 | ||||
| STTK | Shattuck Labs | 0.93 | ||||
| PMVP | Pmv Pharmaceuticals | 0.63 | ||||
| NUVL | Nuvalent | 0.48 | ||||
| EWTX | Edgewise Therapeutics | 0.37 | ||||
| ELYM | Eliem Therapeutics | 1.30 | ||||
| MNOV | MediciNova | 3.37 | ||||
| LYRA | Lyra Therapeutics | 5.00 | ||||
| PHVS | Pharvaris | 7.49 | ||||
| APLT | Applied Therapeutics | 16.06 |
Additional Tools for Theratechnologies Stock Analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.